Evaluation and Management of 11-Month Persistent Cough in a 62-Year-Old Female
This patient has chronic cough (>8 weeks duration) and requires systematic evaluation starting with chest radiography and spirometry, followed by sequential empiric treatment for the most common causes: upper airway cough syndrome (UACS), asthma/eosinophilic bronchitis, and gastroesophageal reflux disease (GERD), with consideration of high-resolution CT (HRCT) and bronchoscopy if initial workup fails to identify the cause. 1
Initial Assessment Priority
Begin by determining if this represents a serious, life-threatening condition requiring urgent evaluation:
- Screen for red flags: Hemoptysis, significant weight loss, dyspnea at rest, fever, night sweats, or signs of systemic disease 2, 3
- Medication review: Specifically ask about ACE inhibitor use (most common drug-related cause) and consider sitagliptin 1, 2
- Smoking history: Essential to document current or past tobacco use 1
- Environmental/occupational exposures: Chemical irritants, allergens, or workplace triggers 2
Essential Baseline Testing
Order immediately:
- Chest radiograph: First-line investigation to exclude malignancy, infection, interstitial lung disease, or cardiac causes 1, 3
- Spirometry: Identifies obstructive airway disease (asthma, COPD) 4, 3
- Complete blood count: May reveal eosinophilia suggesting asthmatic or eosinophilic bronchitis 5
Sequential Empiric Treatment Approach
The ACCP guidelines emphasize that cough may be the only manifestation of common causes, requiring adequate treatment trials (both appropriate agents and sufficient duration) 1. Multiple causes often coexist, necessitating sequential and additive therapy.
First-Line Treatment (Weeks 1-4)
1. Upper Airway Cough Syndrome (UACS)
- Most common cause of chronic cough
- Treat empirically with first-generation antihistamine/decongestant combination
- Look for postnasal drip, throat clearing, nasal discharge, or sinus pressure (though these may be absent)
- Consider nasal endoscopy or sinus CT only if symptoms suggest chronic rhinosinusitis 3
2. Asthma/Cough-Variant Asthma
- May occur without wheezing or dyspnea
- Initiate inhaled corticosteroid (ICS) therapy
- Consider fractional exhaled nitric oxide (FeNO) testing if available to support diagnosis 3
- Bronchial challenge testing if spirometry normal but asthma suspected 3
Second-Line Treatment (Weeks 4-8)
3. Gastroesophageal Reflux Disease
- Up to 75% of patients with reflux-related cough lack typical heartburn or regurgitation 6
- Start high-dose proton pump inhibitor (PPI) therapy
- Implement strict dietary modifications and lifestyle changes
- Important: Response may take 2 weeks to several months 1
- Critical update: Acid suppression alone is no longer recommended as sole therapy 2
If partial or no response:
- Add prokinetic agent (metoclopramide) 1
- Consider 24-hour esophageal pH monitoring (though interpretation criteria remain controversial) 1
- Recognize that nonacid reflux may persist despite PPI therapy 1
Advanced Diagnostic Evaluation
If all initial treatments fail after adequate trials:
HRCT Chest Scan
Perform HRCT to evaluate for:
- Bronchiectasis: Consider especially with chronic productive cough or recurrent infections 7
- Occult interstitial lung disease
- Diffuse panbronchiolitis: If patient has lived in Japan, Korea, or China 8
Bronchoscopy Indications
Proceed to bronchoscopy if:
- HRCT reveals bronchiectasis or interstitial disease
- Even if HRCT is normal, perform bronchoscopy to detect:
- Endobronchial tumor
- Sarcoidosis
- Suppurative lower airway infection
- Eosinophilic or lymphocytic bronchitis 1
Additional Considerations
- Tuberculosis screening: In endemic areas, obtain sputum for acid-fast staining 1
- Laryngoscopy: If hoarseness present 3
- Pertussis testing: If paroxysmal cough with post-tussive vomiting (though less likely at 11 months) 8
Refractory Chronic Cough Management
If complete workup fails to identify treatable cause:
Non-Pharmacologic Interventions
- Speech and language therapy/physiotherapy: First-line for refractory cough 2, 4
- Cough suppression techniques and behavioral interventions 9, 5
Neuromodulator Therapy
Consider trial of:
- Gabapentin (preferred) or amitriptyline 4
- These address cough hypersensitivity syndrome, increasingly recognized as underlying mechanism 10, 6
Emerging Therapies
Critical Pitfalls to Avoid
- Inadequate treatment duration: Each empiric trial requires sufficient time (typically 2-4 weeks minimum, longer for GERD) 1
- Missing ACE inhibitor-related cough: Always discontinue and observe for 4 weeks before extensive workup 1, 2
- Assuming typical symptoms are required: Cough may be the only manifestation of asthma, GERD, or UACS 1
- Premature diagnosis of "unexplained cough": Complete the full diagnostic algorithm first 1
- Overlooking multiple simultaneous causes: Treat additively, not just sequentially 1
Follow-Up Strategy
- Routine follow-up at 4-6 weeks after initial evaluation 2
- Use validated cough severity or quality-of-life tools (Leicester Cough Questionnaire, Cough Severity Diary) to objectively assess response 2, 10
- Consider referral to cough specialist if symptoms persist despite complete workup and appropriate therapeutic trials 1, 2
Note on female predominance: Women show higher prevalence of chronic cough, possibly related to hormonal factors, heightened cough reflex sensitivity, and cough hypersensitivity phenotype 11. This patient's demographic fits the typical profile for refractory chronic cough.